Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infusion Reactions”

Showing 12 of 0 results

Not applicableStudy completedNCT00743431
What this trial is testing

Caelyx in Ovarian Cancer: Prevention and Treatment of Infusion Reactions and Palmar-plantar Erythrodysesthesia (Study P04085)(COMPLETED)

Who this might be right for
Ovarian Neoplasms
Merck Sharp & Dohme LLC 224
Large-scale testing (Phase 3)Study completedNCT00324298
What this trial is testing

Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganTesticular Germ Cell Tumor
Queen Mary University of London 210
Testing effectiveness (Phase 2)Study completedNCT03635684
What this trial is testing

Evaluation of Efficacy and Safety of Subcutaneous Acetaminophen

Who this might be right for
PainFeverDrug Effect+1 more
Saint-Joseph University 31
Testing effectiveness (Phase 2)Study completedNCT04198623
What this trial is testing

Efficacy of Montelukast in Reducing the Incidence and Severity of Monoclonal Antibodies Associated Infusion Reactions

Who this might be right for
Infusion ReactionMonoclonal Antibody
University of California, San Francisco 40
Large-scale testing (Phase 3)Study completedNCT04175834
What this trial is testing

Comparing Risk and Severity of IRRs in Patients Premedicated With Cetirizine vs. Diphenhydramine Prior to Ocrelizumab

Who this might be right for
Multiple SclerosisInfusion Reaction
Providence Health & Services 19
Early research (Phase 1)Study completedNCT04495478
What this trial is testing

Ramucirumab (LY3009806) in Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05663866
What this trial is testing

Premedication to Reduce Amivantamab Associated Infusion Related Reactions

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLC 68
Not applicableWithdrawnNCT04388722
What this trial is testing

Monitoring Noninvasively for Infusion and Transfusion Optimization

Who this might be right for
Post Operative HemorrhageTransfusion Related ComplicationBlood Transfusion Associated Adverse Reactions+1 more
Masimo Corporation
Not applicableStudy completedNCT04555980
What this trial is testing

Warm Patch Decrease Propofol Injection Pain

Who this might be right for
Pain SyndromePropofol Infusion SyndromeInjection Site Irritation
First People's Hospital of Chenzhou 120
Not applicableUnknownNCT03420560
What this trial is testing

A Warmer Temperature Decrease Propofol Injection Pain

Who this might be right for
Injection Site IrritationPropofol SyndromeTemperature Change, Body
Xingui Dai 120
Post-approval studies (Phase 4)Study completedNCT00003252
What this trial is testing

Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
Rush North Shore Medical Center
Testing effectiveness (Phase 2)Study completedNCT01468077
What this trial is testing

A Study in Patients With Moderate to Severe Active Rheumatoid Arthritis Comparing Different Infusion Durations of RoActemra/Actemra (Tocilizumab) Treatment

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 47

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation